(Q46640994)

English

The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial

retracted scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

retracted paper

3 references

Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742.

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

Alzheimer's disease

0 references

randomized controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

0 references

author name string

Tomohiro Kanoko

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

Kei Satoh

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

Jun Iwamoto

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

JAMA Internal Medicine

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

165

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

15

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

1737-1742

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

is retracted by

Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742.

1 reference

Wikimedia import URL

https://www.wikidata.org/w/index.php?title=Wikidata:Property_proposal/is_retracted_by&oldid=745255802

Risk factors for hip fracture among elderly patients with Alzheimer's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Utility of medical and drug history in fracture risk prediction among men and women

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

A population-based study on the association between dementia and hip fractures in 85-year olds.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Calcium homeostasis of an elderly population upon admission to a nursing home

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Fracture risk in patients with Alzheimer's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Psychiatric illness and mortality after hip fracture.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

“Mini-mental state”

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Beneficial effect of etidronate therapy in immobilized hip fracture patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Psychiatric illness predicts poor outcome after surgery for hip fracture: a prospective cohort study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Cost analysis of hip fracture treatment among the elderly for the public health services: a 1-year prospective study in 106 consecutive patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Effect of Vitamin D on falls: a meta-analysis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Fractures after stroke.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/ARCHINTE.165.15.1737

Identifiers

10.1001/ARCHINTE.165.15.1737

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087821

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46640994&oldid=2123672240"